A recent survey reveals that over two-thirds (67%) of UK General Practitioners (GPs) express a desire to prescribe assistive technologies to their dementia patients upon diagnosis, according to research published today. The survey, conducted nationally among GPs, was carried out by the Longitude Prize on Dementia, funded by the Alzheimer's Society and Innovate UK, and delivered by Challenge Works. Its aim was to gauge primary care doctors' willingness to employ technology to aid people and families grappling with dementia.
A yearning for assistive technologies
GPs, particularly, wish to see the development of new technologies tailored to help individuals with dementia maintain their independence. Nearly 88% of GPs believe that individuals with dementia residing in their homes can lead more fulfilling lives, with 77% asserting that it would enhance their lifespan. However, 83% of GPs express frustration that their dementia patients lack adequate support at home. While some existing technologies cater to people with dementia, the focus is often on monitoring rather than supporting daily activities, a concern shared by 86% of surveyed GPs.
Tech that enables independence
Remaining at home can pose challenges for those with dementia, including issues such as loss of confidence, anxiety while navigating their surroundings, medication reminders, and difficulty recognising people. Many GPs believe responsive tech like intuitive apps for navigation, medication reminders, or smart glasses that identify individuals could benefit their patients.
Challenging stereotypes
Challenging the stereotype that older individuals shy away from technology, 49% of GPs report that the majority of their early-stage dementia patients use technology in their daily lives. Additionally, 64% of GPs recommend technology-related strategies to their dementia patients, such as adding medication reminders to smartphones and smart speakers.
Need for adaptive technologies
The survey underscores the importance of considering dementia's progressive nature when designing assistive technologies to ensure they adapt to changing conditions. While 87% of GPs believe early-stage dementia patients would benefit from technology designed for their condition, 84% feel that technologies intended for general use (like phones, tablets, and TVs) do not adequately consider dementia patients' needs.
Longitude Prize on Dementia
The Longitude Prize on Dementia, a £4.42 million initiative, aims to create personalised, technology-based tools co-developed with individuals in the early stages of dementia. These tools aim to help them live independent, fulfilling lives and continue enjoying their interests. In total, £3.42 million will be awarded in seed funding and development grants to promising solutions, with a £1 million grand prize in 2026. The initiative recently announced 24 semi-finalists working on assistive technologies for dementia, ranging from virtual reality devices to augmented reality navigation apps, each receiving grants of £80,000.
These technologies offer hope for a brighter future for individuals living with dementia, enhancing their independence and overall quality of life.
ReplyReply to allForward |
